Article Details

MeiraGTx's Parkinson's gene therapy shows promise in Phase I/II study

Retrieved on: 2024-10-16 20:54:36

Tags for this article:

Click the tags to see associated articles and topics

MeiraGTx's Parkinson's gene therapy shows promise in Phase I/II study. View article details on hiswai:

Summary

The article describes MeiraGTx’s promising results in a gene therapy trial for Parkinson’s using AAV-GAD, showcasing advancements in gene delivery and therapy. Business intelligence principles enhance research and industry strategy. Tags highlight key scientific aspects.

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up